5轮融资之后 IPO折戟!澎立生物欲卖身给它!

国际金融报
14 Feb

近年来,不少药企试图通过“1+1>2”谋求发展。近期,上海奥浦迈生物科技股份有限公司发布公告,公司正在筹划拟以发行股份及支付现金的方式购买澎立生物医药技术(上海)股份有限公司(下称“澎立生物”或“标的公司”)的控制权,同时募集配套资金。募集对象包括PL HK、红杉恒辰、高瓴辰钧等共31名交易对方,本次交易,奥浦迈共购买澎立生物100%的股权。经初步测算,本次交易预计构成《上市公司重大资产重组管理...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10